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doi:10.1016/j.ejvs.2008.12.027Abstract Introduction: Endovascular replacement of failed Vanguard endoprosthesis with
a newly inserted bifurcated Excluder endograft in 6 selected patients over a 10-year period
is reported.
Report: Six male patients were treated by secondary EVAR procedures for endograft failure
(type I and/or III endoleaks caused by endograft disintegration and/or migration). All failed en-
dografts (1 tube, 5 bifurcated) were Vanguard prostheses. Technically, a new bifurcated
Excluder endograft was placed within the old failing Vanguard endograft. All reinterventions
were performed under local anesthesia supplemented by systemic analgesia/sedation. In
3 patients, insertion of the new Excluder endograft was possible without any additional tech-
nical measure as the failing Vanguard endograft trunk had migrated distally. In another
3 patients, the failed Vanguard endograft trunk was still in place. In these patients, the
Vanguard main body was pulled caudally with a transfemoral cross-over guide wire in order
to gain sufficient length to allow the short limb of the Excluder endograft to open within
the trunk of the failed Vanguard endoprosthesis. This guide wire was introduced through
a second femoral 5F in the main access and exeteriorized with a snare through the contralat-
eral 12 Fr sheath. The main body and short limb of the Excluder was then deployed whilst
pulling on the cross-over wire.
Results: Six patients initially treated by a Vanguard endograft underwent complete relining
with a newly inserted Excluder bifurcated stentgraft. The mean interval from the first EVAR
procedure to the described replacement procedure was 75 20.2 months (range: 53e109)., PhD, Clinic for Cardiovascular Surgery, University Hospital of Zurich, Raemistrasse 100, 8091 Zurich,
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Pull-Down Technique to Allow Complete Endovascular Relining 55The new bifurcated Excluder endografts were successfully deployed in all patients (technical
success: 100%). Primary sealing (defined as absence of endoleaks type I, III or IV in the postop-
erative contrast enhanced CT scan) was achieved in 6 of the 6 patients. There was no operative
mortality. No further endovascular or open treatment was needed in the other 5 patients.
During the mean follow-up period of 26 20.1 months (range 2.5e50 months), 2 patients died
from unrelated causes.
Conclusion: Secondary endovascular replacement of failed Vanguard endografts with a bifur-
cated Excluder endograft proved to be feasible and safe with no 30-day mortality. Technical
detail requires traction on a cross-over wire to pull the old graft caudally and create enough
space for the new bifurcated graft to be deployed.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Secondary interventions after endovascular aneurysm
repair (EVAR) have attracted considerable attention during
the past years. In a recent meta-analysis, 16.5% of EVAR
patients required secondary surgical or percutaneous
interventions.1 In the EUROSTAR registry, the cumulative
rate of secondary interventions was 5%, 9%, 12%, and 15% at
1, 2, 3, and 4 years respectively, indicating the continuing
need for reinterventions in patients after EVAR.2 By the
time long-term endograft failure (type I and/or III endo-
leaks caused by endograft disintegration and or migration)
has occurred, the patients tend to be older and have more
comorbidities than originally so that they are at a higher
operative risk for open surgical correction than they origi-
nally were. Thus there are real advantages to salvaging the
failed EVAR endovascularly. We herein report our experi-
ence of complete endovascular relining with a newly
inserted bifurcated Excluder endograft in 6 patients with
failed Vanguard endoprosthesis over a 10-year period.
Report
Six male patients were treated by secondary EVAR proce-
dures for endograft failure (type I and/or III endoleaks
caused by endograft disintegration and or migration) and
received a complete relining with a second bifurcated
modular endograft placed within the first failing endograft.
The mean age at the time of their first intervention was
65 9.12 years (range: 54e76), and at the time of their
second intervention was 77 5.68 years (range: 59e81).
The mean logistic EUROSCORE3 predicting mortality at the
time of the second operation was 14.17 (range: 4.9e29.7).
Three patients were in ASA class III and 3 patients in ASA
class IV. Four of the 6 patients presented with lower back
pain and were treated in an urgent setting, 2 were
asymptomatic and electively treated.
All failing endografts (1 tube, 5 bifurcated) were
Vanguard prostheses (Boston Scientific, Oakland, NJ,
U.S.A.). Graft configurations at the first intervention and
the causes for endograft failures are presented in Table 1.
All patients received a newly placed bifurcated Excluder
endograft (W.L Gore & Associates, Inc., Flagstaff, Arizona,
U.S.A.).
All secondary interventions were performed in an
angiographic suite with optimal fluoroscopy because the
overlay of the old and new stents and markers of theendografts may be confusing and challenging. In all
patients, a femoral cut-down was performed unilaterally to
introduce the 18 Fr sheath for the introduction of the main
body and a contralateral percutaneous access was used for
the introduction of the contralateral limb of the new device
via a 12 Fr sheath. All reinterventions were performed
under local anaesthesia supplemented by systemic anal-
gesia/sedation.
Reinterventions were planned according to the most
recent contrast enhanced computed tomography (CT) data
set with additional multi-planar reconstructions obtained
during follow-up. Particular attention was paid to the
location of the old stent-graft bifurcation, as the distance
between the lowest renal artery and the failing endograft
bifurcation has to be longer than the sum of the body and
contralateral (short) limb length of the new bifurcated
system. When there was a type Ia endoleak with proximal
endograft body migration into the aneurysm sac (nZ 3 in
this series), an Excluder endograft was easily inserted since
the Vanguard’s 54 mm long main body is well suited to fit in
a new device with a relatively short main body (total length
of body and contralateral short limb equals 7 cm for the
Excluder). If the main body was disintegrated but still in
place, the Vanguard main body was pulled caudally with
a transfemoral 0.035’’ cross-over guide wire introduced
through a second contralateral femoral 5F access and
exteriorized as a buddy wire with a snare (Microvena White
Bear Lake, MN, U.S.A.) through the left sided-12 Fr sheath
through which the measuring pigtail catheter also runs,
before deploying the main body and short limb of the
Excluder. This wire, additionally, serves as a marker for the
bifurcation of the failed endograft (Figs. 1e7).
The mean interval from the first to the second (relining)
intervention was 75 20.2 months (range: 53e109). At the
time of the second intervention, the mean aneurysm sac
diameter was 64 11.8 mm (range: 50e80), 11 mm larger
than the initial preoperative sac diameter (mean
53 6.7 mm, range: 41e60).
The new bifurcated Excluder endografts were success-
fully deployed in all patients. In one patient, an additional
left transbrachial artery access with a pull-through wire
was necessary to straighten out the kinked contralateral
Vanguard limb. In another patient, a stent (JOSTENT SelfX,
Abbott) was used to treat a persistent dissection of the
common iliac artery. Primary sealing (defined as absence of
endoleaks type I, III or IV in the postoperative contrast
enhanced CT scan) was achieved in 6 of the 6 patients.
Table 1 Graft type and configuration for first and second intervention.
Patient 1st Graft type and
configuration
Types of reinterventions before
2nd intervention
(months after 1st intervention)
Indication for 2nd intervention
(months after 1st intervention)
2nd Graft type and
configuration
1 Vanguard bifurcated Left renal artery stent (52) Top stent (crown) disintegration;
Caudal (trunk) migration;
Endoleak type III; EIA & CIA
enlargement (þ25%). (109)
Excluder bifurcated
2 Vanguard bifurcated Extension stentgraft due to Top stent (crown) disintegration
Caudal (trunk) migration; Kinking
at bifurcation level; Endoleak
type I; Endoleak type II. (82)
Excluder bifurcated
Limb disconnection
Endoleak type III (27)
PTA of endograft limb (59)
3 Vanguard bifurcated No reintervention Top stent (crown) disintegration;
Endoleak type Ib (right); Endoleak
type III (left); Tear in iliac limb
graft; Imminent rupture. (60)
Excluder bifurcated
4 Vanguard bifurcated No reintervention Top stent (crown) disintegration;
Fractured nitinol stents (53)
Excluder bifurcated
5 Vanguard tube No reintervention Aneurysm enlargement (þ40%);
Ectatic aneurysm encircled the
proximal end of prosthesis with
kinking; Endoleak type I. (65)
Excluder bifurcated
6 Vanguard bifurcated Extension stentgrafts to right
CIA and left EIA
Top stent (crown) disintegration;
Caudal trunk migration; AAA
enlargement (þ70%). (80)
Excluder bifurcated
Distal graft dislocation
Coil Embolization IIA
PTA of endograft limb due to
endoleak type I b
AAA enlargement (þ50%) (62)
Legend. EIAZ External iliac artery; CIAZ Common iliac artery; IIAZ Internal iliac artery; PTAZ Percutaneous transluminal
angioplasty.
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obstructions in the postoperative contrast enhanced CT
scan. No conversion to open surgery was necessary.
There was no 30-day mortality. Perioperative complica-
tions occurred in 1 of the 6 patients. A groin haematoma
with associated lymphatic fistula required surgical evacu-
ation. A contralateral lymphatic fistula in the same patient
resolved with aspiration and compression. Two months
after endograft relining, this patient required a common
femoral to superficial femoral artery bypass and a subse-
quent transobturator external iliac to tibioperoneal artery
bypass for progressive peripheral arterial occlusive disease.
Overall, hospital length of stay was 4.7 days (range: 3e8).
No patient required a stay in the intensive care unit.
During the follow-up period of 26 20.1 months (range:
2.5e50) the maximum aneurysm sac diameter remained
unchanged in 4 patients. In one patient, reduction of
maximum aneurysm diameter of 10% was observed at
1 year. In another patient, the aneurysm sac enlarged more
than 20% in 3 years, but additional endovascular procedures
were not performed because of the patient’s wishes and his
poor general condition. In this patient there was no
evidence of an endoleak on CT angiogram. Therefore,
endotension, which is known to occur with first generation,
high-permeability PTFE-Excluder devices was assumed. Nofurther endovascular or open treatment was needed in the
other 5 patients. During the follow-up period, 2 patients
died from unrelated causes.Discussion
Long-term endograft failure (type I and/or III endoleaks
caused by endograft disintegration and or migration)
usually requires correction by endovascular or surgical
intervention. According to the underlying problem, there
are several types of endovascular secondary interventions
to treat failed endografts.4 For type I endoleaks, ballooning
of the involved area with a compliant balloon will occa-
sionally fix the problem. However, cuffs or balloon
expandable Palmaz stents are usually required. The effi-
cacy of proximal cuffs to achieve sealing of type I endoleaks
is only 45%.5 In patients with type III endoleaks, coverage of
the defect by the use of a bridging cuff or a new limb could
result in the resolution of the endoleak.6
In recent reports, partial relining by endovascular
intervention has been reported. In 3 patients with endo-
tension, the combination of a proximal aortic cuff and a new
endograft limb extension resulted in aneurysm sac regres-
sion.7 The biggest case series of patients with attempts to
Figure 1 After the femoral cut-down, a 5 Fr sheath is first
introduced just caudal to the planned introduction site of the
18 Fr sheath for introduction of the trunk of the new bifurcated
endograft. The 18 Fr sheath is then introduced over a 0.035’’
stiff wire as for the usual EVAR procedure. On the contralateral
side, a 12 Fr sheath is inserted percutaneously.
Figure 2 The 0.035’’ cross-over wire (red) running through
the 5 Fr sheath is catched with a contralateral transfemoral
snare that has been introduced through the percutaneous 12 Fr
sheath.
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reported in patients with endotension due to original high
permeability of Excluder endografts. The relining was per-
formed by covering any portion of the first endograft that
was within the aneurysm sac (i.e. not in contact to the
aortic wall) with new low-porosity Excluder endograft
components.8 Before these reports, all patients requiring
secondary interventions for endotension due to original
high-permeability Gore Excluder endografts, required open
surgical conversion with explantation of the endograft.9
However, perioperative mortality was high, 22% in one
series of 38 patients converted to open repair.10 In contrast
to the open surgical management, the method of endolu-
minal endograft relining offers a minimally invasive treat-
ment option for endotension and/or type I, type III or type
IV endoleaks. However, the use of a complete new sten-
tgraft is more predictably effective.6 The vast majority of
reported patients with complete relining of failed endog-
rafts were initially treated with tube grafts.5,11e13 Only one
article describes complete relining of a failed bifurcated
endograft with a new bifurcated stent graft.14In our series, 5 of 6 patients were initially treated by
a Vanguard bifurcated endograft and 1 by a Vanguard tube
graft. All patients underwent complete relining with
a newly inserted Excluder bifurcated stentgraft. We chose
to use this type of endograft because in comparison to
other commercial devices, the Excluder endograft is rather
flexible and requires a smaller introducer sheath.
Furthermore, the relatively short main body of the
Excluder endoprosthesis allows the short leg to open above
the old endograft bifurcation whereas this would not be
possible with other stentgrafts with longer bodies because
the short limb of the new endograft would open in the
ipsilateral limb of the old endograft. In certain cases,
however, the failed endograft (type I and/or III endoleaks
caused by endograft disintegration and or migration) has to
be pulled down by traction on a cross-over wire in order to
get more room to implant the new endograft without
jailing the new short limb. If the defect lies close to the
old endograft bifurcation or the original failing graft is
short bodied or fixed with hooks or barbs in the suprarenal
aorta, that prevent pulling the graft downwards, secondary
Figure 3 The 0.035’’ cross-over wire is exteriorized through
the contralateral 12 Fr sheath by pulling the snare and
concomitantly pushing the cross-over wire. Once exteriorized,
both ends are gently pulled under fluoroscopic control. Note
that the bifurcation of the old failed endograft is pulled
caudally 2e2.5 cm thereby increasing the distance from the
renal arteries to the bifurcation (total length of body and
contralateral short limb equals 70 mm for the Excluder as
opposed to 54 mm for the Vanguard). Hereby, the trunk of the
Vanguard is pulled down into the aneurysm sack.
Figure 4 The new bifurcated Excluder endograft is then
inserted through the 18 Fr sheath and placed just at the level
of the renal arteries. It is crucial to check under fluoroscopic
control that the marker of the short contralateral limb of the
new bifurcated endograft lies above the cross-over wire
marking the bifurcation of the old, failed Vanguard endograft.
Once ensured that there is enough distance, the body and the
contralateral short limb of the new bifurcated Excluder
endograft are released.
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aorto- uni-iliac endograft with femoro-femoral cross-over
bypass may be the best option. Finally, special caution
should be paid for possible mechanical interaction
between fractured stents of the old device and the coax-
ially introduced new stentgraft to avoid tearing the fabric
of the new graft.15
Follow-up imaging with contrast is mandatory after
complete relining with a secondary endograft to detect
newly developed complications. In 1 of 6 patients, aneu-
rysm sac enlargement of 20% presumably due to endo-
tension was detected. It is encouraging that in all 6 patients
there were no signs of endoleaks due to abrasion or tearing
of the new graft.
There was no operative mortality in this small series of
6 patients. We attribute this low mortality to the minimallyinvasive nature of the endovascular reinterventions carried
out in local anesthesia. For good-risk patients, the poor
durability of secondary endovascular procedures may be
a concern, but when the patient’s general condition is poor,
the use of a secondary endovascular approach is probably
the best option.
In conclusion, complete secondary relining of failed
Vanguard endografts with a new bifurcated Excluder
endograft proved to be feasible and safe with no 30-day
mortality if certain technical steps are carried out. Key
among these techniques is traction on a cross-over wire to
pull the old graft caudally and create enough space for the
new bifurcated graft to be deployed, when necessary. This
technique should be considered when treating failed
primary aortic endografts. However, no conclusions can be
drawn on the treatment of other than failed Vanguard
endografts.
Figure 5 (A) The measuring catheter angiography shows the caudal migration of the Vanguard endograft associated with a type
1a endoleak. (B) In addition, there is kinking of the iliac limbs related to aneurysm shrinkage with a right-sided late type 1b
endoleak and also a late left-sided type 3 endoleak.
Figure 6 Pull-down manoeuvre via a cross-over wire (long
arrowhead ) which also serves as a marker for the failed
endograft bifurcation. Note the disintegrated crown of the
Vanguard endograft (short arrowhead ). Inset: The intra-
operative angiography before releasing the new Excluder
endograft shows the marker of the contralateral Excluder leg
(thick arrow) just above the cross-over wire (thin arrow) which
indicates the level of the Vanguard’s bifurcation.
Figure 7 The completion angiogram after total relining with
an Excluder device depicts repair of all three endoleaks related
to the late Vanguard failure.
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